Efficacy of vaccination against severe COVID-19 in relation to Delta variant and time since second dose: the REACT-SCOT case-control study
View ORCID ProfilePaul M McKeigue, View ORCID ProfileDavid A McAllister, Sharon J Hutchinson, Chris Robertson, Diane Stockton, View ORCID ProfileHelen M Colhoun, for the PHS COVID-19 Epidemiology and Research Cell
doi: https://doi.org/10.1101/2021.09.12.21263448
Paul M McKeigue
1Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, Scotland
6Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
David A McAllister
2Institute of Health and Wellbeing, University of Glasgow, 1 Lilybank Gardens, Glasgow G12 8RZ
6Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Sharon J Hutchinson
3School of Health and Life Sciences, Glasgow Caledonian University. SH - Professor of Epidemiology and Population Health
6Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Chris Robertson
4Department of Mathematics and Statistics, University of Strathclyde, 16 Richmond Street, Glasgow G1 1XQ
6Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Diane Stockton
6Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Helen M Colhoun
5Institute of Genetics and Cancer, College of Medicine and Veterinary Medicine, University of Edinburgh, Western General Hospital Campus, Crewe Road, Edinburgh EH4 2XUC, Scotland
6Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
6Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Posted September 15, 2021.
Efficacy of vaccination against severe COVID-19 in relation to Delta variant and time since second dose: the REACT-SCOT case-control study
Paul M McKeigue, David A McAllister, Sharon J Hutchinson, Chris Robertson, Diane Stockton, Helen M Colhoun, for the PHS COVID-19 Epidemiology and Research Cell
medRxiv 2021.09.12.21263448; doi: https://doi.org/10.1101/2021.09.12.21263448
Efficacy of vaccination against severe COVID-19 in relation to Delta variant and time since second dose: the REACT-SCOT case-control study
Paul M McKeigue, David A McAllister, Sharon J Hutchinson, Chris Robertson, Diane Stockton, Helen M Colhoun, for the PHS COVID-19 Epidemiology and Research Cell
medRxiv 2021.09.12.21263448; doi: https://doi.org/10.1101/2021.09.12.21263448
Subject Area
Subject Areas
- Addiction Medicine (357)
- Allergy and Immunology (681)
- Anesthesia (182)
- Cardiovascular Medicine (2697)
- Dermatology (231)
- Emergency Medicine (406)
- Epidemiology (12336)
- Forensic Medicine (10)
- Gastroenterology (773)
- Genetic and Genomic Medicine (4181)
- Geriatric Medicine (393)
- Health Economics (690)
- Health Informatics (2704)
- Health Policy (1011)
- Hematology (366)
- HIV/AIDS (865)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3962)
- Nursing (216)
- Nutrition (587)
- Oncology (2090)
- Ophthalmology (597)
- Orthopedics (245)
- Otolaryngology (309)
- Pain Medicine (254)
- Palliative Medicine (76)
- Pathology (474)
- Pediatrics (1136)
- Primary Care Research (464)
- Public and Global Health (6596)
- Radiology and Imaging (1431)
- Respiratory Medicine (879)
- Rheumatology (416)
- Sports Medicine (347)
- Surgery (458)
- Toxicology (56)
- Transplantation (192)
- Urology (170)